# Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor

> **NCT02627521** · PHASE4 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 260 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** PRU guided CABG
- **PROCEDURE:** CABG per standard of care
- **DEVICE:** VerifyNow assay
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02627521
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627521, "Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02627521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*